Davis's Drug Guide
lumasiran
General
Pronunciation:
loo-ma-sir-an
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Oxlumo
Ther. Class.
none assigned
Pharm. Class.
hydroxyacid oxidase 1 (HAO1) directed small interfering ribonucleic acid (siRNA)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Lumasiran." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580025/all/lumasiran.
Vallerand AHA, Sanoski CAC, . Lumasiran. Davis's Drug Guide. F.A. Davis Company; 2025. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580025/all/lumasiran. Accessed January 15, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Lumasiran. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580025/all/lumasiran
Vallerand AHA, Sanoski CAC, . Lumasiran [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 January 15]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580025/all/lumasiran.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - lumasiran
ID - 3580025
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580025/all/lumasiran
PB - F.A. Davis Company
ET - 19
DB - Medicine Central
DP - Unbound Medicine
ER -
